Autoimmune diseases in horses refer to conditions where the horse's immune system mistakenly targets its own tissues, leading to inflammation and tissue damage. These diseases can affect various systems in the body, including the skin, joints, and blood cells. Common autoimmune conditions in horses include pemphigus foliaceus, equine recurrent uveitis, and immune-mediated hemolytic anemia. Diagnosis often involves a combination of clinical signs, laboratory tests, and histopathological examination. Management of autoimmune diseases typically includes immunosuppressive therapies to reduce immune system activity. This page compiles peer-reviewed research studies and scholarly articles that explore the pathogenesis, diagnosis, and treatment of autoimmune diseases in equine health.
Equine recurrent uveitis serves as a spontaneous model for human autoimmune uveitis. Unpredictable relapses and ongoing inflammation in the eyes of diseased horses as well as in humans lead to destruction of the retina and finally result in blindness. However, the molecular mechanisms leading to inflammation and retinal degeneration are not well understood. An initial screening for differentially regulated proteins in sera of uveitic cases compared to healthy controls revealed an increase of the alternative pathway complement component factor B in ERU cases. To determine the activation status ...
Pfeiffer CJ, Spurlock S, Ball M.Pemphigus foliaceus is an uncommon dermatologic disorder occurring in several species and has been reported in horses during the past decade. An ultrastructural analysis of affected skin of horses presenting to our clinics has revealed early cytopathologic features of pemphigus-like disease, some of which closely resemble pemphigus foliaceus in the human, calve, and guinea pig. Prior to complete acantholysis and bullae formation, the intercellular spaces enlarged, but intercellular bridges and desmosomes remained intact. A novel finding was presence of aggregates of electron dense granular mat...
Bello K, Lorch G, Papich MG, Kim K, Toribio RE, Yan L, Xie Z, Hill K, Phelps MA.Additional immunomodulatory treatment is needed for the management of immune-mediated disease in horses. Mycophenolate mofetil (MMF) is an immunomodulatory agent used in human and veterinary medicine for the prevention of graft rejection and the management of autoimmune diseases. Few studies exist investigating the pharmacokinetics of MMF in horses. The aim of this study was to evaluate the pharmacokinetics of a single dose of MMF in healthy horses in the fed vs. fasted state. Six healthy Standardbred mares were administered MMF 10 mg/kg by a nasogastric (NG) tube in a fed and fasted state. ...
